Apelin

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameApelin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApelin receptor agonists
TargetsApelin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Cardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of CambridgeAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of CambridgeAstrazeneca PlcMedimmune Llc
Inactive CompaniesThe University Of Edinburgh
Active IndicationsDiabetes Mellitus, Type 2Cardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia